D Hartmann1. 1. Klinik und Poliklinik für Dermatologie und Allergologie, Klinikum der Universität München, LMU München, Frauenlobstr. 9-11, 80337, München, Deutschland. Daniela.Hartmann@med.uni-muenchen.de.
Abstract
BACKGROUND: Ex vivo confocal laser scanning microscopy (CLSM) enables bedside histology and offers the surgeon a direct intraoperative tissue examination. OBJECTIVES: To determine whether this innovative, ultra-fast diagnostic tool can be expanded beyond nonmelanoma skin cancer, particularly basal cell carcinoma, to other indications including melanocytic lesions and autoimmune diseases. MATERIALS AND METHODS: Review of literature and summary of the current knowledge and experience of the use of ex vivo CLSM in melanocytic lesions and in autoimmune diseases. RESULTS: Up to date experience of the use of ex vivo CLSM in melanocytic lesions and in autoimmune diseases is limited but promising. Current knowledge on melanocytic lesions in ex vivo CLSM and their examples together with classic ex vivo CLSM features are presented. Previous results on the use of ex vivo CLSM in autoimmune dermatoses are presented, and future application possibilities of ex vivo CLSM are discussed. CONCLUSIONS: The method is particularly suitable for the rapid examination of basal cell carcinomas during Mohs surgery but could also be used in the future for the intraoperative examination of melanocytic and autoimmune skin lesions.
BACKGROUND: Ex vivo confocal laser scanning microscopy (CLSM) enables bedside histology and offers the surgeon a direct intraoperative tissue examination. OBJECTIVES: To determine whether this innovative, ultra-fast diagnostic tool can be expanded beyond nonmelanoma skin cancer, particularly basal cell carcinoma, to other indications including melanocytic lesions and autoimmune diseases. MATERIALS AND METHODS: Review of literature and summary of the current knowledge and experience of the use of ex vivo CLSM in melanocytic lesions and in autoimmune diseases. RESULTS: Up to date experience of the use of ex vivo CLSM in melanocytic lesions and in autoimmune diseases is limited but promising. Current knowledge on melanocytic lesions in ex vivo CLSM and their examples together with classic ex vivo CLSM features are presented. Previous results on the use of ex vivo CLSM in autoimmune dermatoses are presented, and future application possibilities of ex vivo CLSM are discussed. CONCLUSIONS: The method is particularly suitable for the rapid examination of basal cell carcinomas during Mohs surgery but could also be used in the future for the intraoperative examination of melanocytic and autoimmune skin lesions.
Authors: Caterina Longo; Alice Casari; Francesca Beretti; Anna Maria Cesinaro; Giovanni Pellacani Journal: J Am Acad Dermatol Date: 2011-10-14 Impact factor: 11.527
Authors: Caterina Longo; Alice Casari; Barbara De Pace; Silvia Simonazzi; Giovanna Mazzaglia; Giovanni Pellacani Journal: Skin Res Technol Date: 2012-06-07 Impact factor: 2.365
Authors: Giovanni Pellacani; Alon Scope; Barbara Ferrari; Gaia Pupelli; Sara Bassoli; Caterina Longo; Anna Maria Cesinaro; Giuseppe Argenziano; Rainer Hofmann-Wellenhof; Josep Malvehy; Ashfaq A Marghoob; Susana Puig; Stefania Seidenari; H Peter Soyer; Iris Zalaudek Journal: J Am Acad Dermatol Date: 2009-10-14 Impact factor: 11.527
Authors: M Manfredini; G Mazzaglia; S Ciardo; F Farnetani; V D Mandel; C Longo; S Zauli; V Bettoli; A Virgili; G Pellacani Journal: J Eur Acad Dermatol Venereol Date: 2014-09-26 Impact factor: 6.166
Authors: T Maier; E C Sattler; M Braun-Falco; H C Korting; T Ruzicka; C Berking Journal: J Eur Acad Dermatol Venereol Date: 2012-02-10 Impact factor: 6.166